Study of the Impact of DPD Activity on the Efficacy of Capecitabine
Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates the Impact of DihydroPyrimidine Dehydrogenase (DPD) activity on the
efficacy of Capecitabine in patients with metastatic breast cancer. The DPD phenotype before
the initiation of treatment will be assess and then the patient will be follow up during the
treatment with Capecitabine up to 24 month.